- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Express Scripts Makes Value-Based Decisions for its Formulary
The pharmacy benefit manager has decided to choose formulations that provide equivalent benefit at lower cost.
Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by .
The company will continue to include Procrit, a similar anemia drug sold by , on its list of preferred drugs, or formulary.
"The products we have chosen to exclude from our formulary are those that cost significantly more than other available options but that fail to provide additional health benefit," the company said in an emailed statement.
Scripts, which like other pharmacy benefit managers administers prescription drug benefits for employers and health plans and runs large mail-order pharmacies, said that patients who fill a prescription for an excluded drug will pay the full retail price.
Epogen, and second-generation drug Aranesp, have been hugely profitable for Amgen, although their use has waned in recent years due to safety concerns, including increased risk of heart problems. Still, the two drugs generated U.S. sales of $2.7 billion last year.
Link to the report: http://reut.rs/1v1jdn0
Source: Reuters
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
